Second-Line Chemotherapy Use in Metastatic Colon Cancer Varies by Disease Responsiveness

2008 ◽  
Vol 7 (1) ◽  
pp. 55-59 ◽  
Author(s):  
Seth Politano ◽  
Michael Overman ◽  
Priyanka Pathak ◽  
Romil Chadha ◽  
Katrina Glover ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Metastatic Colon Cancer ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

scholarly journals Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients

2014 ◽  
Vol 31 (7) ◽  
pp. 724-734 ◽  
Author(s):  
Zhiyuan Zheng ◽  
Eberechukwu Onukwugha ◽  
Nader Hanna ◽  
Kaloyan Bikov ◽  
Brian Seal ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Cost Effectiveness ◽  
Cancer Patients ◽  
Metastatic Colon Cancer ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

scholarly journals Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients

2014 ◽  
Vol 3 (1) ◽  
pp. 124-133 ◽  
Author(s):  
Zhiyuan Zheng ◽  
Nader Hanna ◽  
Eberechukwu Onukwugha ◽  
Emily S. Reese ◽  
Brian Seal ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Cancer Patients ◽  
Metastatic Colon Cancer ◽  
Second Line ◽  
Chemotherapy Treatment ◽  
First Line ◽  
Second Line Chemotherapy ◽  
Line Chemotherapy

A Case of Duodenal Neuroendocrine Carcinoma Treated with Amrubicin as Second-line Chemotherapy

2015 ◽  
Vol 24 (3) ◽  
pp. 379-382
Author(s):  
Tadahisa Inoue ◽  
Hitoshi Sano ◽  
Takashi Mizushima ◽  
Hirotada Nishie ◽  
Hiroyasu Iwasaki ◽  
...  
Keyword(s):  
Neuroendocrine Carcinoma ◽  
Distant Metastases ◽  
Salvage Chemotherapy ◽  
Second Line ◽  
Effective Treatment Option ◽  
Second Line Chemotherapy ◽  
Best Response ◽  
Long Term Effect ◽  
Line Chemotherapy

We present the case of a Japanese man in his 60s with duodenal neuroendocrine carcinoma with distant metastases. Chemotherapy with irinotecan plus cisplatin was initiated as a first-line regimen. However, disease progression was observed after only two cycles. Therefore, amrubicin was administered as a second-line chemotherapy. The patient showed a long-term effect of amrubicin therapy, and the best response was a partial response after seven cycles. For duodenal neuroendocrine carcinoma, amrubicin therapy can be considered an effective treatment option as salvage chemotherapy.

FOLFOX as Second-Line Chemotherapy for Advanced Biliary Tract Cancer

2020 ◽  
Author(s):  
Angela Lamarca ◽  
Daniel Palmer ◽  
Harpreet Wasan ◽  
Paul J. Ross ◽  
Yuk Ting Ma ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Second Line ◽  
Second Line Chemotherapy ◽  
Tract Cancer ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document